Safety and Tolerance of Increased Doses of HRS-5346 Tablets in Healthy Subjects

Clinical trial NCT06441227 · COMPLETED

Trial details

NCT number: NCT06441227
Sponsor: Shandong Suncadia Medicine Co., Ltd.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Lipoprotein Disorder Disease

Start date: 2024-06-13
Primary completion: 2025-01-09
Enrollment: 71

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.